Date : 26 June 2026

| Ecosystem Segment | Key Participants | Role in Market |
| Technology Providers | Haemonetics, Terumo, LivaNova, Medtronic, Fresenius Kabi | Develop cell salvage and autotransfusion technologies |
| Product Manufacturers | Haemonetics, Terumo, LivaNova, Braile Biomédica, EUROSETS | Manufacture autotransfusion systems and disposables |
| Service Providers | Hospital groups, surgical centers, perfusion service providers | Operate autotransfusion systems during procedures |
| Platform Providers | Haemonetics, LivaNova, Terumo | Integrated blood management platforms and perfusion ecosystems |
| CROs/CDMOs | Not a major segment in this market | Limited relevance due to device-centric nature |
| Software Vendors | Haemonetics, LivaNova | Procedure monitoring, automation, workflow management |
| Research Institutions | Major cardiovascular and surgical research hospitals across Brazil, Mexico, Argentina, and Chile | Clinical validation and PBM protocol development |
| End-User Industries | Hospitals, Cardiac Centers, Orthopedic Centers, Trauma Centers, Transplant Centers | Primary purchasers and users of autotransfusion systems |
R&D
Regulatory Approvals
Patient Support and Services
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Haemonetics Corporation | Boston, Massachusetts | USA | Global autotransfusion leader; strongest dedicated cell salvage franchise | Cell Saver Elite+, Cell Saver 5+ |
| Terumo Corporation | Tokyo | Japan | Major cardiovascular and blood management supplier across Latin America | Advanced Perfusion Systems, Autotransfusion Solutions |
| LivaNova PLC | London | United Kingdom | Strong cardiac surgery and extracorporeal circulation portfolio | XTRA Autotransfusion System |
| Medtronic plc | Galway | Ireland | Significant cardiac surgery presence and perfusion-related technologies | Blood management and cardiac surgery solutions |
| Fresenius Kabi AG | Bad Homburg, Hesse | Germany | Strong transfusion medicine and hospital blood management footprint | Blood processing and transfusion technologies |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| EUROSETS | Medolla, Modena | Italy | Specialized perfusion and autotransfusion manufacturer | Electa Autotransfusion System |
| Braile Biomédica | São José do Rio Preto, São Paulo | Brazil | Leading Latin American cardiovascular device manufacturer | Cell salvage and perfusion products |
| B. Braun Melsungen AG | Melsungen, Hesse | Germany | Strong surgical blood management and transfusion technologies | Perfusion and blood management systems |
| Asahi Kasei Medical | Tokyo | Japan | Active in extracorporeal blood processing technologies | Blood purification and processing systems |
| Teleflex Incorporated | Wayne, Pennsylvania | USA | Surgical and critical care portfolio supporting blood management workflows | Surgical blood conservation solutions |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Redax S.p.A. | Poggio Rusco, Mantua | Italy | Growing presence in cardiothoracic blood management | Autotransfusion and drainage systems |
| LivaNova Deutschland GmbH | Munich, Bavaria | Germany | Specialized regional cardiopulmonary solutions deployment | Autotransfusion accessories and perfusion systems |
| Sorin Group Italia | Milan, Lombardy | Italy | Legacy cardiac surgery technologies still active through installed base | Blood management systems |
| Getinge AB | Gothenburg | Sweden | Increasing focus on cardiac surgery and extracorporeal support technologies | Perfusion and cardiovascular support systems |
| Xenios AG | Heilbronn, Baden-Württemberg | Germany | Niche extracorporeal circulation specialist supporting blood management procedures | ECLS and blood circulation technologies |
The Latin America autotransfusion devices market size was estimated at USD 58.4 million in 2025 and is predicted to increase from USD 62.43 million in 2026 to approximately USD 113.81 million by 2035, expanding at a CAGR of 6.9% from 2026 to 2035.

Speak with a healthcare analyst about your research, consulting, or platform needs.